Press release 📈 Stocks 🌍 Netherlands

Lapsi Health Appoints Former Philips Executive Fabia Tetteroo-Bueno to Board

Clinical AI startup Lapsi Health adds former Philips Latin America CEO Fabia Tetteroo-Bueno to its board, leveraging her two decades of healthcare leadership to support the company's strategic growth.

📅 October 29, 2026 🕐 1 min read

2 assets impacted (Stocks). Net bias: 0 Bullish, 0 Bearish, 2 Neutral. Strongest signal: Lapsi Health → 2/10 (60% confidence).

📊 Affected Assets (2)

Lapsi Health

Neutral 🤖 60%

📅 Short-term 🌍 NL · Explicit

Appointment of a seasoned healthcare executive to the board may support Latin American expansion but has no immediate financial impact.

PHG

Neutral 🤖 65%

📅 Short-term 🌍 NL · Explicit

Former Philips Latin America CEO joins another company's board, which does not affect Philips' operations or financials.

🎯 Key Takeaways

Fabia Tetteroo-Bueno joins Lapsi Health board following a 20-year career in global healthcare.
The appointment marks a strategic move for the Dutch AI firm as it seeks to expand its clinical footprint.
Tetteroo-Bueno previously served as the first female leader of Philips in the Latin American market.

📝 Executive Summary

Lapsi Health, the Dutch clinical AI firm behind the Keikku platform, has appointed Fabia Tetteroo-Bueno to its board of directors. Tetteroo-Bueno brings over 20 years of global healthcare experience, including her previous tenure as the first woman to lead Philips in Latin America.

❓ FAQ

Who is Fabia Tetteroo-Bueno?

Fabia Tetteroo-Bueno is a seasoned healthcare executive who previously served as the first woman to lead Philips in Latin America.

What is Lapsi Health?

Lapsi Health is a Dutch clinical AI company that developed the Keikku platform.

📰 Related Articles

🏷️ Tags

📰 Source

🔗 View Original Article